← Leaderboards
Christina Tenenhaus Dann
Trustees Of Indiana University
$1,547,788
Attributed
$1,547,788
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $299.1K · FY2010–16$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$1,547,788 · 2
By mechanism
R01$1,170,488 · 1
R21$377,300 · 1
Top collaborators
No co-investigators on record.
Most similar at Trustees Of Indiana University
Same institution · by research overlap
- Malcolm E Winkler$10,575,795
- Lydia Jane Bright$102,496
- Ming Li$1,382,833
Others in their field
Top investigators on “Somatic Cell”
- Dennis R. Burton · Scripps Research Institute$261,087,746
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$64,910,059
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Linda M Brzustowicz · Rutgers The St Univ Of Nj New Brunswick$50,800,152
- Rudolf Jaenisch · Whitehead Institute For Biomedical Res$32,217,463
- Supriya Menezes · The Emmes Company, Llc$25,277,032
Research focus
Somatic CellTumorigenesisMediatingSelf-RenewalStem Cell DifferentiationTransplantationEmbryonic Stem CellIn VitroMolecularProteinsGene TherapyStemStem CellsTestisCellsAutologous TransplantationGerm CellsCell TypeBaseEmbryoMouse ModelMutationEngineeringFoundations
Grant awards (6)
Molecular control of spermatogonial stem cell fate for achieving cell therapy$296,061
R01 · FY2016 · HD · contact PI
Molecular control of spermatogonial stem cell fate for achieving cell therapy$291,575
R01 · FY2015 · HD · contact PI
Molecular control of spermatogonial stem cell fate for achieving cell therapy$283,800
R01 · FY2013 · HD · contact PI
Molecular control of spermatogonial stem cell fate for achieving cell therapy$299,052
R01 · FY2012 · HD · contact PI
Gene therapy using homologous recombination in mouse spermatogonial stem cells$184,800
R21 · FY2011 · HD · contact PI
Gene therapy using homologous recombination in mouse spermatogonial stem cells$192,500
R21 · FY2010 · HD · contact PI